Scanning and combinatorial library services – Save 20% with code TRY-BXPLIB-20

Categories

Category: Customer stories


November 17, 2021

Empowering Scientists to Make Breakthrough Discoveries to Address Humanity’s Greatest Challenges

Codex DNA’s mission is to drive innovation and apply breakthroughs in automation solutions for DNA, mRNA, and protein synthesis. These tools enable scientists to “write” biology for the betterment of the world, creating sustainable healthcare and technology solutions for humanity’s…


November 12, 2021

PEGS Europe 2021: The Recap

The Codex DNA team recently attended PEGS Europe, held this year in Barcelona, Spain. With over 200 speakers including 15 keynote addresses, the conference brings together scientific professionals to discuss the latest developments in protein and antibody engineering, cell and…


August 11, 2021

With mRNA Capping Technology, We’re Improving Synthesis Yields

If you’re working with synthetic mRNA, we have exciting news to share. In addition to releasing a new workflow earlier this year that makes it possible to synthesize mRNA form pooled oligos in a single overnight run on our BioXp™…


August 4, 2021

Unlock the potential of BioXp™ automation solutions for bio-fuel production

Our BioXp™ automated end-to-end benchtop system has been used by scientists in many different focus areas to advance breakthroughs in protein engineering. We are delighted to share a great example of utilizing BioXp gene and clone workflows to build recombinant…


June 23, 2021

Case study: How Cellibre transformed enzyme engineering with Codex DNA

In San Diego, scientists at ag biotech startup Cellibre are looking to replace traditional agriculture for producing high-value ingredients. One of their first targets is the highly valuable cannabinoid market, which they believe can be disrupted by producing natural, high-quality,…


May 26, 2021

Scientists use automated DNA synthesis to identify response to antimicrobial threats

Scientists use automated DNA synthesis to identify regulatory mechanism in E. coli response to antimicrobial threats. Bacterial resistance to antibiotics is a looming public health crisis, and scientists continue to investigate how to better characterize the molecular mechanisms underpinning this…


May 19, 2021

Countering emerging SARS-CoV-2 variants webinar recap: Four key takeaways

Last week, we had the opportunity to partner with Jesse Erasmus, Acting Assistant Professor of the University of Washington School of Medicine and Director of Virology at HDT Bio, presenting a webinar titled Development of a replicon RNA vaccine platform…


April 28, 2021

Codex DNA presents webinar: Countering emerging SARS-CoV-2 variants with Dr. Jesse Erasmus

The global COVID-19 pandemic caused by the novel SARS-CoV-2 coronavirus created an urgent need for protective interventions. Fortunately, new advances in vaccine development — including nucleic acid-based approaches — have enabled the unprecedented rollout of multiple vaccine products within a…


March 24, 2021

For HIV vaccine study, scientists build pooled variant library using automated DNA synthesis

The quest for an effective vaccine against HIV has spanned decades. While the vaccine itself remains elusive, researchers are making important strides in figuring out how best to design and develop it. Recently, scientists from Duke University and NIH’s Vaccine…


Contact us

The expertise of our scientists, engineers and supporting teams are at your service! Submit the form below and/or call us at 858.526.3080.

This field is for validation purposes and should be left unchanged.

By clicking Submit, you agree that Codex DNA may use this information to contact you about our programs, products, or services. You may opt out at any time.

Your personal data is handled according to our privacy policy. In addition, if you are located within a distributor territory, you may be contacted directly by them. We never sell your data to anyone.